Current Edition

Volume 16 Issue 3

Combating Counterfeit Drugs: A Multifaceted Approach

Counterfeiting and diversion are global issues that impact virtually every industry, with no organisation immune to the potential damage. Across markets, counterfeit...
Continue Reading →
Volume 16 Issue 3

Studies Support Changing Perspectives Of Glass Vial Performance Characteristics

The global market for glass pharmaceutical containers is projected to exceed $10.5 billion within the next three years, solidifying glass as arguably the most widely...
Continue Reading →
Volume 16 Issue 3

Unlocking the Secrets: Long-term Storage Effects on Pharmaceutical Proteins in Glass and Polymer Prefilled Syringes

In the last few decades, the pharmaceutical industry has experienced rapid growth in parenteral products, leading to easier availability of life-saving drugs in the ...
Continue Reading →
Volume 16 Issue 3

The Global Crisis of Counterfeit Pharmaceuticals: A Call to Action

MM Packaging gathers experts in their field to lay the foundations for the conversation about counterfeit pharmaceuticals; looking into the realities, impact, and po...
Continue Reading →
Volume 16 Issue 3

The Pivotal Role of Patient Advocacy Organisations in Driving Rare Disease Therapeutic Development

Throughout the rare disease clinical development pathway, patient advocacy organisations (PAOs) can and do play crucial roles that exceed supportive functions like r...
Continue Reading →
Volume 16 Issue 3

Listening to the Patient Voice to Improve Eye Care

The growing global ophthalmic eyedroppers market is expected to be driven by the increasing prevalence of eye disease and disorders such as Glaucoma, Dry Eye Disease...
Continue Reading →
Volume 16 Issue 3

How Efficient Logistics Can Change the Lives of Rare Disease Patients

Dr. Danial Arkwell, Head of Global Key Accounts, Pharma at Envirotainer highlights the vital role of efficient logistics in mitigating risk and finding the right sol...
Continue Reading →
Volume 16 Issue 3

The Primary Logistics Needs of Life Science Companies

The low volume life science market has significant complexities when it comes to logistics. Shippers must have an educated understanding of Good Distribution Practic...
Continue Reading →
Volume 16 Issue 3

In Silico Modelling for Orally Inhaled and Nasal Drug Product Development

Q&A with Will Ganley, Senior Specialist, Nanopharm. Can you Explain ‘in Silico Modelling’ and What a PBPK Model is? In silico modelling involves using comp...
Continue Reading →
Volume 16 Issue 3

Keep Breathing! SMIs Deliver More: SMIs Deliver Higher Single Breath Doses than Nebulisers

MRX004 SMI delivers single breath doses 3 to 5 times higher than nebulisers. We contend that nebulisers are serial SMIs and only achieve mg delivered doses because o...
Continue Reading →